FIRST IN CLASS FIXED COMBINATION QUINOLONE-NSAID FOR BACTERIAL CONJUNCTIVITIS (OPHTHALMOLOGY, OCULAR INFECTIONS, INFLAMMATION)

TiAHEAL Powder Spray is ideal for exudative wounds such as abrasions, minor burns, skin lesions, sores, fissures, cuts, small surgical wounds etc. Kaolin allows control of exudates while hyaluronic acid and TiAB facilitate the natural healing process by protection from exogenous microbial proliferation and...

Iridya system is a multidose preservative free device, with advanced ergonomics, drop control, microbiological safety and flexible viscosity adjustment, with “no jet” technology.

From the combination of the moisturizing and protective qualities of Sodium Hyaluronate with the technological adva...

First in class ointment in the market enriched with Hyaluronic Acid. This product, thanks to Hyaluronic Acid and its isotonic characteristic, has been specifically formulated to offer effective symptoms relief for patients suffering from moderate to severe dry eye, kerato-conjunctivitis sicca and noct...

Specifically formulated to offer effective symptoms relief for patients suffering from dry eye syndrome and to stimulate epithelial corneal reparation in case of corneal erosion, burns, after ocular surgery (cataract and refractive) and in prolonged use of contact lenses .

Ophthalmic gel...

Aminoacids stabilize sodium hyaluronate viscosity during blinking, ensuring its distribution and adhesion onto the corneal surface and favouring its hydrating and protective effect. Synergy between Aminoacids and Sodium Hyaluronate leads to tear film stability and corneal reparation. Preservative f...

The product has been specifically formulated as an adjuvant in blepharitis treatment. This product contains a derivative of Tea Tree Oil (Terpinen-4-ol) characterized by an anti-inflammatory, antimicrobial and acaricidal activity against Staphylococcus aureus and Demodex (either directly or by carrying...

First in class combination of a quinolone and a steroid for the treatment of Otitis externa and Media with Perforated Tympanic Membrane supported by phase III clinical study performed at European level. Please contact us for more information and to discuss partnership on a global scale. Presentation: ...

First innovative colonoscopy preparation that allows the patient to be prepared on the same day of colonoscopy. The reconstituted solution has a slightly sugary taste recognized as very pleasant by patients, it’s easy to take and it requires only 750 ml of water, improving patient compliance with treat...

The efficacy of the TiAB complex is NOW available in a new GREEN cap, derived from sustainable red seaweed based carrageenan, for all those consumers seeking an animal free alternative. The NEW TiAB Soft VEGICAPS formulation is indicated as adjuvant in the treatment of bacterial, fungal and viral infection...

Biovaginil is a food supplement with Lactobacillus Crispatus and vitamin A.  L. Crispatus is a specific probiotic strains with a clear indication (NTCVAG04) that strongly correlates with the absence of Bacterial Vaginitis and is the only Lactobacillus species associated with low pH, negative whiff...

TiABLO, ophthalmic gauzes soaked in TiAB solution, provides unbeatable cleaning and protection. TiAB is a complex of Silver, a powerful antiseptic and Titanium, that maintain Silver in its active formula. TiABLO kills common bacteria responsible for ocular infections. It is especially recommended in tr...

Levofloxacin-Dexamethasone eye drops solution is the first combination approved for the management of patients undergoing cataract surgery able to prevent infection and ensure complete control of inflammation with one week treatment. Levofloxacin-Dexamethasone combines the power of the most ac...

A pharmacovigilance study published confirms the safety of fixed-dose eye drops for post-cataract surgery 17 Jul, 2025A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination eye drop containing an anti-inflammatory steroid and a quinolone antibiotic, developed by NTC, indicated for the prevention and treatment of inflammation and prevention of infection following cataract surgery in adults. The study was submitted when nearly 4 million patients across about 60 countries worldwide were treated with this drug.

 

Advanced scientific research and technology drive our efforts to innovate care practices.
Our range of products builds from our historical vocation for innovation aimed at improving the experience of patients and healthcare practices.
An innovation aimed at discovering specific therapeutic gestures: simple and intuitive,  sustainable, and technically advanced for empowering the patient.
Our research aims to put pioneering new products within the reach of everyone and to optimize the
performance of our products by analyzing the daily needs and habits of people undergoing treatment.
We research, develop and produce innovative drugs, medical devices and food supplements.
We market our products worldwide through licensing, distribution, marketing, and commercial deals with partner companies.
Our core therapeutic areas are: Ophthalmology, Gastro-Metabolism, Pediatrics and Gynacology.

A new in vitro study shows that a 2% concentration of TiAB—a compound based on silver-bound titanium dioxide—is sufficient to exert strong bactericidal activity within 24 hours against Gram-negative bacteria and support wound healing.

It describes our 2024 journey

Our products 

NTC: Novelty

NTC Technology

NTC Care